Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial

PURPOSE: The adoption of hypofractionated whole-breast irradiation (HF-WBI) remains low, in part because of concerns regarding its safety when used with a tumor bed boost or in patients who have received chemotherapy or have large breast size. To address this, we conducted a randomized, multicenter...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Oncol
Prif Awduron: Shaitelman, Simona F., Lei, Xiudong, Thompson, Alastair, Schlembach, Pamela, Bloom, Elizabeth S., Arzu, Isidora Y., Buchholz, Daniel, Chronowski, Gregory, Dvorak, Tomas, Grade, Emily, Hoffman, Karen, Perkins, George, Reed, Valerie K., Shah, Shalin J., Stauder, Michael C., Strom, Eric A., Tereffe, Welela, Woodward, Wendy A., Amaya, Diana N., Shen, Yu, Hortobagyi, Gabriel N., Hunt, Kelly K., Buchholz, Thomas A., Smith, Benjamin D.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2018
Pynciau:
ORIGINAL REPORTS
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286164/
https://ncbi.nlm.nih.gov/pubmed/30379626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00317
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg